Sector group

Technology & Engineering

The Technology & Engineering landscape is evolving, with new innovations driving change across industries. Our team helps to protect and commercialise cutting-edge developments in this dynamic environment.

Our Technology & Engineering Group is at the forefront of protecting innovation across the full spectrum of engineering and high-tech sectors. Combining deep technical expertise with strategic IP insight, we advise clients ranging from startups to multinational corporations on securing and defending their intellectual property rights in fast-moving and complex fields and navigating the IP rights of others.

With backgrounds in disciplines such as electronics, mechanical engineering, computer science, and telecommunications, our attorneys understand the technologies that drive today’s innovation. We work closely with inventors, R&D teams and in-house IP departments to draft robust patent applications, navigate prosecution globally, and develop IP strategies that align with commercial objectives.

Whether it’s advanced manufacturing, robotics, AI, semiconductors, or emerging digital technologies, we help our clients turn technical excellence into strong, valuable IP portfolios.

Latest updates

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article

Computer-implemented Inventions

Video overview: To obtain a patent for a CII in Europe, two main hurdles must be cleared: Eligibility A claim must have technical character—even one technical feature is enough. Examples …

Read article

Bioinformatics at the EPO

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. …

Read article